AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ATOMO DIAGNOSTICS LTD

0.016

+0.000

Volume:571.00K

Turnover:9.61K

Market Cap:10.23M

PE:-1.59

High:0.017

Open:0.016

Low:0.016

Close:0.016

Loading ...

Overview Company News Filings

Building a better breed of hybrid

ASX Market Close: Index treads water on Budget Eve | Monday March 25, 2025

The Market Herald

Atomo Diagnostics Signs Exclusive Licensing Agreement for Novel Rapid Syphilis Test Assay; Shares Rise 12%

MT Newswires Live

BUZZ-Australia's Atomo Diagnostics rises on licensing agreement for Syphilis test

BRIEF-Atomo Diagnostics Says Exclusive Licence For Novel Syphilis Test On Pascal Secured

Atomo Diagnostics - Exclusive Licence for Novel Syphilis Test on Pascal Secured

THOMSON REUTERS

More headwinds for income investors

BUZZ-Australia's Atomo Diagnostics jumps on $3.4 mln HIV test supply deal

Atomo Diagnostics Signs Supply Agreement with UK Diagnostic Test Provider; Shares Up 6%

MT Newswires Live

BRIEF-Atomo Diagnostics Secures Long Term Agreement With Newfoundland

Atomo Diagnostics - Agreement for Exclusive Distribution Rights to Supply Co's Test in UK, Others

THOMSON REUTERS

Atomo Diagnostics - Deal for a$5.44M

THOMSON REUTERS

Atomo Diagnostics Ltd - Secures Long Term Agreement With Newfoundland

THOMSON REUTERS

Asset managers see opportunities in APRA’s bank hybrid ban

The Australian Financial Review

Atomo Diagnostics Ltd-Atomo Secures Australian Order for Supply of Hiv Self-Tests

THOMSON REUTERS

A new era for tactical fixed income

Atomo Diagnostics secures $2.44m grant to develop first rapid active syphilis self-test

Atomo Diagnostics Ltd-Atomo Secures $2.44M Grant to Develop Syphilis Test

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AT1.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AT1.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AT1.AU\",,,,,undefined,":{"symbol":"AT1.AU","market":"AU","secType":"STK","nameCN":"ATOMO DIAGNOSTICS LTD","latestPrice":0.016,"timestamp":1743743520000,"preClose":0.016,"halted":0,"volume":570997,"delay":0,"nameEN":"ATOMO DIAGNOSTICS LTD","floatShares":305462639,"shares":639202310,"eps":-0.010087,"marketStatus":"Market Closed","change":0,"latestTime":"04-04 16:12:00 AEDT","open":0.016,"high":0.017,"low":0.016,"amount":9612,"amplitude":0.0625,"askPrice":0.017,"askSize":175178,"bidPrice":0.016,"bidSize":235671,"shortable":3,"etf":0,"ttmEps":-0.010087,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1743984000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.016,"openAndCloseTimeList":[[1743721200000,1743742800000]],"volumeRatio":4.465484202301902,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AT1.AU\",,,,,undefined,":{"symbol":"AT1.AU","floatShares":305462639,"roa":"-31.72%","roe":"-61.15%","lyrEps":-0.010789,"volumeRatio":4.465484202301902,"shares":639202310,"dividePrice":0,"high":0.017,"amplitude":0.0625,"preClose":0.016,"low":0.016,"week52Low":0.016,"pbRate":"1.38","psRate":"2.43","week52High":0.044,"institutionHeld":0,"latestPrice":0.016,"committee":0.147239,"eps":-0.010087,"divideRate":0,"volume":570997,"delay":0,"ttmEps":-0.010087,"open":0.016,"prevYearClose":0.019,"prevWeekClose":0.017,"prevMonthClose":0.017,"prevQuarterClose":0.017,"fiveDayClose":0.017,"twentyDayClose":0.018,"sixtyDayClose":0.019,"earningDate":1745942400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AT1.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524522408","title":"Building a better breed of hybrid","url":"https://stock-news.laohu8.com/highlight/detail?id=2524522408","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524522408?lang=en_us&edition=fundamental","pubTime":"2025-04-03 13:10","pubTimestamp":1743657017,"startTime":"0","endTime":"0","summary":"The phase-out of bank hybrid securities has begun, and the $43 billion currently invested, needs to be deployed elsewhere. Investors can construct a hybrid of bank debt and equity securities to replace outgoing bank hybrids. However, we think they can do better by taking a diversified, yet active multi-asset approach to investing that emphasises income generation and quality in equities, and duration management in debt.Is it possible for hybrid investors to do better than a synthetic of bank equity and debt?We believe so. In the first place, most hybrids are floating rate notes. This means that as interest rates move up and down, the coupons that are paid out on these securities move up and down as well, with a short delay. Therefore, as interest rates fall, the risk is that hybrid coupons also fall. Further, there is re-investment risk, because in a lower rate environment, hybrid investors are forced to reinvest into lower yielding options. Investors end up being","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/building-a-better-breed-of-hybrid","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/building-a-better-breed-of-hybrid","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["AT1.AU","BK7501","BK7007","BK7145","LIC.AU"],"gpt_icon":0},{"id":"2521742089","title":"ASX Market Close: Index treads water on Budget Eve | Monday March 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521742089","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521742089?lang=en_us&edition=fundamental","pubTime":"2025-03-24 14:08","pubTimestamp":1742796480,"startTime":"0","endTime":"0","summary":"Discretionary was the best performing sector, up 1.1%, followed by Financials, up 1%.Staples was the worst performing sector, down 1.7%, followed by Information Technology, down 1%, and Industrials, down 0.9%. Metal Hawkclosed up 1.25% after securing firm commitments from investors to raise $2.5 million through a private placement at 41c per share, representing a 3.8% premium to last closing price. The funds will support an extensive maiden drilling program at the Thylacine and Siberian Tiger prospects within the Leinster South Project in WesternAustralia.Atomo Diagnostics closed up 5.9% after inking an exclusive global licence to commercialise a groundbreaking rapid syphilis test developed by the Burnet Institute.Errawarra Resourcesclosed up 107% after it acquired high-grade Elizabeth Hill Silver Project in the West Pilbara region. The company secured a 70% interest in the historic silver mine as well as rights to surrounding tenements covering 180sqkm.New Hope  has finished down 4.3%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-index-treads-water-on-budget-eve-monday-march-25-2025-2025-03-24/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7083","BK4086","MHK.AU","BK7506","LU1559883803.SGD","BK7044","BK7007","LU0566484027.USD","NHC.AU","SM1.AU","BK7141","BK7095","AZEK","ERW.AU","BK7501","JHX.AU","AT1.AU","BK7505","BK7509"],"gpt_icon":0},{"id":"2521755517","title":"Atomo Diagnostics Signs Exclusive Licensing Agreement for Novel Rapid Syphilis Test Assay; Shares Rise 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2521755517","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521755517?lang=en_us&edition=fundamental","pubTime":"2025-03-24 11:42","pubTimestamp":1742787737,"startTime":"0","endTime":"0","summary":"Atomo Diagnostics  obtained an exclusive licensing agreement with the Burnet Institute for its novel rapid Syphilis test assay, carving a path to commercialization for the product, according to a Monday filing with the Australian bourse.The agreement will enable Atomo to commercialize the test on its Pascal test cassette, the filing stated. Atomo will pay Burnet a royalty fee as a percentage of the net revenue generated by the product.The agreement is in effect until Burnet's Syphilis patent expires in 2045.Atomo Diagnostics' shares were up nearly 12% in recent Monday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AT1.AU","BK7501","BK7007"],"gpt_icon":0},{"id":"2521581857","title":"BUZZ-Australia's Atomo Diagnostics rises on licensing agreement for Syphilis test","url":"https://stock-news.laohu8.com/highlight/detail?id=2521581857","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521581857?lang=en_us&edition=fundamental","pubTime":"2025-03-24 11:17","pubTimestamp":1742786266,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Atomo Diagnostics rises on licensing agreement for Syphilis test** Shares of Atomo Diagnostics AT1.AX fall 11.8% to A$0.019, their biggest intraday pct jump since mid-August** The medical device firm hits highest level since March 14** Co signs an exclusive licensing agreement with the Burnet Institute for their novel rapid Syphilis test** Says license gives co exclusive rights to commercialise the test  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL3N3Q7086:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7007","AT1.AU"],"gpt_icon":0},{"id":"2521172735","title":"BRIEF-Atomo Diagnostics Says Exclusive Licence For Novel Syphilis Test On Pascal Secured","url":"https://stock-news.laohu8.com/highlight/detail?id=2521172735","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521172735?lang=en_us&edition=fundamental","pubTime":"2025-03-24 09:20","pubTimestamp":1742779207,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Says Exclusive Licence For Novel Syphilis Test On Pascal SecuredMarch 24 (Reuters) - Atomo Diagnostics Ltd AT1.AX:EXCLUSIVE LICENCE FOR NOVEL SYPHILIS TEST ON PASCAL SECUREDFurther company coverage: AT1.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q50HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","AT1.AU","BK7501"],"gpt_icon":0},{"id":"2521735643","title":"Atomo Diagnostics  - Exclusive Licence for Novel Syphilis Test on Pascal Secured","url":"https://stock-news.laohu8.com/highlight/detail?id=2521735643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521735643?lang=en_us&edition=fundamental","pubTime":"2025-03-24 09:16","pubTimestamp":1742778995,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q50HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","AT1.AU","BK7501"],"gpt_icon":0},{"id":"2517600959","title":"More headwinds for income investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600959","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517600959?lang=en_us&edition=fundamental","pubTime":"2025-03-05 09:37","pubTimestamp":1741138623,"startTime":"0","endTime":"0","summary":"Income-focussed investors face more challenges this year post the fall in interest rates, equity yields, and interest in bank hybrids weakens.The Reserve Bank’s 0.25% rate cut in February potentially signals the start of lower rates for new term deposit holders this year. With the market pricing in another two 0.25% rate cuts by year’s end[i], the trend for term deposit rates is down, although the size and speed of rates cuts could be tempered by persistent higher inflation.In equities, the average dividend yield on Australian shares has edged lower since 2022 and is now below 4%.[ii] With some large-cap miners cutting their dividend in the latest earnings-reporting season, and some Australian banks reporting earnings below market expectation, the dividend outlook is clouded.Then there’s bank hybrids. In December 2024, the Australian Prudential Regulation Authority  announced that the $45-billion bank hybrid market[iii] will be phased out between now and 2032.[iv]. These are tectonic s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/more-headwinds-for-income-investors","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/more-headwinds-for-income-investors","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7007","AT1.AU","BK7501","XKO.AU","XAO.AU","XJO.AU"],"gpt_icon":0},{"id":"2503814560","title":"BUZZ-Australia's Atomo Diagnostics jumps on $3.4 mln HIV test supply deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2503814560","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503814560?lang=en_us&edition=fundamental","pubTime":"2025-01-14 10:37","pubTimestamp":1736822253,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Atomo Diagnostics jumps on $3.4 mln HIV test supply deal** Atomo Diagnostics AT1.AX soars as much as 11.1% to A$0.020; biggest intraday gain since Dec. 5, 2024** Medical devices maker","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nL4N3OA05L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1051770623.HKD","SGXZ57979304.SGD","LU0889565080.SGD","LU0011850046.USD","LU0171293334.USD","LU1989771016.USD","LU0211327993.USD","SG9999013999.USD","LU2023251221.USD","IE0002141913.USD","LU0310800379.SGD","LU1880407132.USD","LU0738911758.USD","LU0964806797.USD","03165","LU1481599808.USD","LU0997586432.USD","LU0128525689.USD","LU0052756011.USD","AZN.UK","IE00BFTCPJ56.SGD","LU0963555726.SGD","LU0345777659.USD","LU0526926950.USD","LU2468319806.SGD","LU1057294990.SGD","LU1267930573.SGD","LU0211326755.USD","LU0784384876.USD","LU2324357040.USD","LU0047473722.EUR","LU1291159041.SGD","BK5011","LU1267930227.SGD","LU1989772923.USD","LU0047473722.SGD","LU1814569148.SGD","LU0575583348.USD","LU0640478417.SGD","LU1267930490.SGD","LU0757432116.USD","LU0949170772.SGD","LU1003077747.HKD","AT1.AU","LU0882574055.USD","LU0969580561.USD","LU1023059063.AUD","LU0266013472.USD","LU1003076772.USD","LU1015430645.USD"],"gpt_icon":0},{"id":"2503569063","title":"Atomo Diagnostics Signs Supply Agreement with UK Diagnostic Test Provider; Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503569063","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503569063?lang=en_us&edition=fundamental","pubTime":"2025-01-14 09:28","pubTimestamp":1736818124,"startTime":"0","endTime":"0","summary":"Atomo Diagnostics  secured an agreement to supply its HIV self-test kit to UK-based Newfoundland Diagnostics, valued at AU$5.4 million over five years, according to a Tuesday filing with the Australian bourse.The agreement, running until June 30, 2030, grants Newfoundland exclusive distribution rights for the company's tests in the UK and non-exclusive rights for the EU and Colombia, the filing said.Atomo Diagnostics shares rose nearly 6% in midday trade Tuesday.Price : $0.02, Change: $+0.0010, Percent Change: +5.56%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","LU0426412945.USD","BK7007","AT1.AU","LU0426417589.USD","BK4125","LU0345774631.USD","AUD","LU2238339852.HKD","LU0994945656.USD","LU1043141123.HKD"],"gpt_icon":0},{"id":"2503047566","title":"BRIEF-Atomo Diagnostics Secures Long Term Agreement With Newfoundland","url":"https://stock-news.laohu8.com/highlight/detail?id=2503047566","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503047566?lang=en_us&edition=fundamental","pubTime":"2025-01-14 09:11","pubTimestamp":1736817109,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Secures Long Term Agreement With NewfoundlandJan 14  - Atomo Diagnostics Ltd AT1.AX:SECURES LONG TERM AGREEMENT WITH NEWFOUNDLANDDEAL FOR  A$5.44MAGREEMENT FOR EXCLUSIVE DISTRIBUTION RIGHTS TO SUPPLY CO'S TEST IN UK, OTHERSFurther company coverage: AT1.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nFWN3O9151:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AT1.AU","BK7501","BK7007"],"gpt_icon":0},{"id":"2503562405","title":"Atomo Diagnostics - Agreement for Exclusive Distribution Rights to Supply Co's Test in UK, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2503562405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503562405?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:52","pubTimestamp":1736805166,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O9151:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","AT1.AU","BK7501"],"gpt_icon":0},{"id":"2503556247","title":"Atomo Diagnostics - Deal for  a$5.44M","url":"https://stock-news.laohu8.com/highlight/detail?id=2503556247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503556247?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:52","pubTimestamp":1736805166,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O9151:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AT1.AU","BK7501","BK7007"],"gpt_icon":0},{"id":"2503455624","title":"Atomo Diagnostics Ltd - Secures Long Term Agreement With Newfoundland","url":"https://stock-news.laohu8.com/highlight/detail?id=2503455624","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503455624?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:52","pubTimestamp":1736805166,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O9151:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AT1.AU","BK7501","BK7007"],"gpt_icon":0},{"id":"2502135241","title":"Asset managers see opportunities in APRA’s bank hybrid ban","url":"https://stock-news.laohu8.com/highlight/detail?id=2502135241","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502135241?lang=en_us&edition=fundamental","pubTime":"2025-01-12 16:14","pubTimestamp":1736669640,"startTime":"0","endTime":"0","summary":"Asset managers are rushing to fill the gap left by a looming ban on widely popular if little-understood bank hybrid securities after the prudential watchdog found they may create a systemic risk in a crisis.The $43 billion hybrid market will be phased out by 2032 in an overhaul that has angered investment advisers. Hybrids – or additional tier 1 capital  – are a core part of bank funding. They can be issued as debt to investors and pay out interest over time, but can be converted to equity or wiped out entirely if required in a crisis, like what happened with the collapse of Credit Suisse early last year.Loading...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/companies/financial-services/asset-managers-see-opportunities-in-apra-s-bank-hybrid-ban-20241231-p5l1cn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["BK7007","AT1.AU","BK7501"],"gpt_icon":0},{"id":"2483506958","title":"Atomo Diagnostics Ltd-Atomo Secures Australian Order for Supply of Hiv Self-Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2483506958","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483506958?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:35","pubTimestamp":1731450901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUE8DSFMY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AT1.AU","BK7501","BK7007"],"gpt_icon":0},{"id":"2481361508","title":"A new era for tactical fixed income","url":"https://stock-news.laohu8.com/highlight/detail?id=2481361508","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481361508?lang=en_us&edition=fundamental","pubTime":"2024-11-06 12:00","pubTimestamp":1730865623,"startTime":"0","endTime":"0","summary":"Australia’s hybrid bond market rarely makes headlines, but in recent weeks it has been firmly back in the spotlight. The Australian Prudential Regulation Authority  recently revealed plans to phase out Australian banks’ use of additional tier one  capital which APRA believes is riskier, thereby seeking to enhance the overall stability of the banking system.The announcement came on the heels of a surge in interest in corporate hybrids sparked by the successful raising for Australian Securities Exchange  listed mall operator Scentre Group . Yarra’s outlook for Australia’s hybrid bond market—of which bank AT1 hybrids make up around $41 billion—considers these latest proposed regulatory changes while focusing on the future potential for hybrids in funding corporate Australia’s energy transition ambitions.For that reason, we expect large blue-chip generation companies like AGL , Origin , APA (ASX:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/a-new-era-for-tactical-fixed-income","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/a-new-era-for-tactical-fixed-income","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7142","AGL.AU","STO.AU","XAO.AU","BK4141","BK4526","XKO.AU","BK7507","BK7148","BK7130","BK7006","ORG.AU","XJO.AU","BK7136","ASX.AU","SCG.AU","BK7007","BK7510","ASX","BK7039","APA.AU","AT1.AU","WPL.AU","BK7005","BK7162","BK7501"],"gpt_icon":0},{"id":"2477859312","title":"Atomo Diagnostics secures $2.44m grant to develop first rapid active syphilis self-test","url":"https://stock-news.laohu8.com/highlight/detail?id=2477859312","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477859312?lang=en_us&edition=fundamental","pubTime":"2024-10-23 08:51","pubTimestamp":1729644696,"startTime":"0","endTime":"0","summary":"Atomo Diagnostics  has again been recognised by the Australian government with the award of a $2.44 million grant to develop a unique syphilis test.The Australian-based medical device company was awarded the CRC-P industry grant from the Department of Industry, Science and Resources  to support the development of an innovative rapid active syphilis test for point-of-care professional use and at-home self-testing.Previous federal government funding also helped expand Atomo’s HIV testing vending machine deployment, creating a significant increase in access to free tests at key locations.Many people with syphilis may not notice any symptoms and they can also go undetected by healthcare providers.If untreated, syphilis can persist for many years and is an increasingly urgent public health challenge globally, with WHO estimating that 8 million people acquired the disease in 2022.A recent report by the Kirby Institute indicated that syphilis diagnoses in Australia have tripled over the last ","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/10/Atomo-Diagnostics-ASX-AT1-CRC-P-industry-grant-syphilis-test.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/10/Atomo-Diagnostics-ASX-AT1-CRC-P-industry-grant-syphilis-test.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/atomo-diagnostics-grant-develop-first-rapid-active-syphilis-self-test/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["XJO.AU","BK7007","XKO.AU","BK7501","AT1.AU","XAO.AU"],"gpt_icon":0},{"id":"2477390994","title":"Atomo Diagnostics Ltd-Atomo Secures $2.44M Grant to Develop Syphilis Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2477390994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477390994?lang=en_us&edition=fundamental","pubTime":"2024-10-23 06:52","pubTimestamp":1729637573,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nTUE8DNJHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AT1.AU","BK7501","BK7007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AT1.AU\",params:#limit:5,,,undefined,":[{"date":"2025-04-30","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745971200000,"name":null,"time":"","dateTimestamp":1745935200000,"actualEps":null},{"date":"2025-02-27","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740610800000,"name":null,"time":"","dateTimestamp":1740574800000,"actualEps":null},{"date":"2025-01-29","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1738105200000,"name":null,"time":"","dateTimestamp":1738069200000,"actualEps":null},{"date":"2024-10-28","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1730070000000,"name":null,"time":"","dateTimestamp":1730034000000,"actualEps":null},{"date":"2024-08-30","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724976000000,"name":null,"time":"","dateTimestamp":1724940000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AT1.AU\",market:\"AU\",,,undefined,":[]}}